Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 41 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations
NCT06716580
- Conditions
- EGFR Gene Mutation, Lung Cancer, Lung Diseases, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute at Steward St. Elizabeth's Brighton, Massachusetts, United States
NCT07548060
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Recruiting
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.
NCT06238882
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +16 more
- Locations
-
- Instituto Nacional de Cancerologia Mexico City, Mexico
NCT06186401
- Conditions
- Astrocytoma, EGFR Gene Mutation, Glioblastoma, +10 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT03042221
- Conditions
- ALK Gene Mutation, BRAF V600E, Bronchial Neoplasms, +13 more
- Locations
-
- University of Colorado, Cancer Center Aurora, Colorado, United States
NCT03175224
- Conditions
- Advanced Cancer, Astrocytoma, Brain Diseases, +64 more
- Locations
-
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- Moffitt Tampa, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- University of North Carolina Chapel Hill, North Carolina, United States
NCT06643000
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
- Henan Cancer Hospital Zhengzhou, Henan, China
Recruiting
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
NCT06222489
- Conditions
- Advanced Non-Small Cell Squamous Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands
NCT06071013
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- China Medical University Hospital Taichung, Taiwan
NCT05598528
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Department of Oncology, The Second Xiangya Hospital, Central South University Changsha, Hunan, China
Recruiting
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
NCT04322890
- Conditions
- ALK Gene Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Yongchang Zhang Changsha, Hunan, China
NCT04085315
- Conditions
- EGFR Gene Mutation, Lung Cancer Metastatic
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT05503667
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
NCT05033691
- Conditions
- Brain Diseases, Brain Metastases, Brain Neoplasms, +18 more
- Locations
-
- Hadassah Ein Kerem Medical Center Jerusalem, Israel
Not Yet Recruiting
In Vitro NSCLC EGFR-Mutant Models for Drug Sensitivity Testing
NCT07697716
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT07461727
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC
NCT06436144
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
Not specified
Not Yet Recruiting
Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)
NCT06323148
- Conditions
- EGFR Gene Mutation, Lung Cancer, Lung Diseases, +11 more
- Locations
-
Not specified
Not Yet Recruiting
The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC
NCT06117644
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
Not specified
Not Yet Recruiting
Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.
NCT06018688
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified